Ovarian cancer researchers find biomarker linked to prognosis in aggressive disease type

Ovarian cancer researchers find biomarker linked to prognosis in aggressive disease type
Dr. Mauricio Medrano, a molecular biologist and research associate at Princess Margaret Cancer Centre, University Health Network. Credit: UHN

Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, the most common and lethal subtype of the disease.

The findings, featured on the cover of the March 7 issue of Cell Reports, show that patients with high levels of the biomarker, CD151, have a poor prognosis, says lead author Mauricio Medrano, a molecular biologist and research associate at Princess Margaret Cancer Centre, University Health Network.

"Ovarian cancer is many diseases," says Dr. Medrano. "By identifying CD151 and its underlying role in cancer cell survival, we hope to develop a therapy to target it. As a marker for poor prognosis, with further research, there is the potential to develop a clinical screening tool to help personalize cancer treatment for patients."

The research was led by principal investigator Dr. Robert Rottapel, senior scientist and Professor, Departments of Medical Biophysics and Immunology, University of Toronto.‚Äč

In lab experiments, the research team used cell lines derived from 40 patient tumour samples to identify that CD151 contributes to the survival of cells of high-grade serous ovarian cancer origin. The team further analysed tissue samples from a cohort of approximately 1,000 patients to establish the correlation of high levels of CD151 to .

"For the scientific community," says Dr. Medrano, "our study provides a lot of new information about other possible targets, not only CD151, that could be important and can provide new ideas for how to target ."

Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, the most common and lethal subtype of the disease. Credit: UHN

Explore further

Immune therapy scientists discover distinct cells that block cancer-fighting immune cells

Journal information: Cell Reports

Citation: Ovarian cancer researchers find biomarker linked to prognosis in aggressive disease type (2017, March 7) retrieved 25 May 2019 from https://medicalxpress.com/news/2017-03-ovarian-cancer-biomarker-linked-prognosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more